Hanan Tanash

1.2k total citations
42 papers, 584 citations indexed

About

Hanan Tanash is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Hanan Tanash has authored 42 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 21 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Hanan Tanash's work include Protease and Inhibitor Mechanisms (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers) and Blood Coagulation and Thrombosis Mechanisms (11 papers). Hanan Tanash is often cited by papers focused on Protease and Inhibitor Mechanisms (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers) and Blood Coagulation and Thrombosis Mechanisms (11 papers). Hanan Tanash collaborates with scholars based in Sweden, United Kingdom and Spain. Hanan Tanash's co-authors include Eeva Piitulainen, Magnus Ekström, Peter M. Nilsson, Gerdt C. Riise, Jan‐Åke Nilsson, Anne Lindberg, Eva Rönmark, Lennart Hansson, Sandra Díaz and Sabrina Bajwah and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Respiratory Journal and Thorax.

In The Last Decade

Hanan Tanash

36 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanan Tanash Sweden 14 298 256 237 143 64 42 584
M. Luisetti Italy 8 254 0.9× 188 0.7× 302 1.3× 116 0.8× 54 0.8× 14 615
Sung-Nam Lim South Korea 12 120 0.4× 140 0.5× 152 0.6× 119 0.8× 31 0.5× 31 455
Robert Virtala Sweden 8 118 0.4× 87 0.3× 174 0.7× 49 0.3× 34 0.5× 8 459
Lijuan Li China 14 100 0.3× 78 0.3× 40 0.2× 170 1.2× 44 0.7× 74 549
Ana Lívia Silva Galbiatti Brazil 15 83 0.3× 99 0.4× 61 0.3× 45 0.3× 40 0.6× 40 542
José R. Borbolla‐Escoboza Mexico 12 33 0.1× 109 0.4× 80 0.3× 46 0.3× 30 0.5× 18 386
Francesca Mariani Italy 16 57 0.2× 59 0.2× 469 2.0× 44 0.3× 41 0.6× 41 647
Habib M. Ghaddar United States 10 62 0.2× 124 0.5× 81 0.3× 173 1.2× 30 0.5× 14 389
Yongqiang Zhao China 9 40 0.1× 60 0.2× 87 0.4× 115 0.8× 63 1.0× 27 557

Countries citing papers authored by Hanan Tanash

Since Specialization
Citations

This map shows the geographic impact of Hanan Tanash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanan Tanash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanan Tanash more than expected).

Fields of papers citing papers by Hanan Tanash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanan Tanash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanan Tanash. The network helps show where Hanan Tanash may publish in the future.

Co-authorship network of co-authors of Hanan Tanash

This figure shows the co-authorship network connecting the top 25 collaborators of Hanan Tanash. A scholar is included among the top collaborators of Hanan Tanash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanan Tanash. Hanan Tanash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santus, Pierachille, Marco Mantero, María Torres‐Durán, et al.. (2025). Characteristics of bronchiectasis in patients with different genotypes of severe α 1 -antitrypsin deficiency from the EARCO registry. ERJ Open Research. 12(1). 491–2025.
2.
Theorell‐Haglöw, Jenny, Martin Ulander, John Brandberg, et al.. (2025). What are the important risk factors for excessive daytime sleepiness in a population‐based cohort?. Journal of Sleep Research. 34(4). e14449–e14449. 2 indexed citations
3.
Núñez, Alexa, Cristina Esquinas, Hanan Tanash, et al.. (2025). Routine Blood Biomarkers and Lung Disease in Patients with Alpha-1 Antitrypsin Deficiency from the EARCO Registry. Respiration. 105(3). 370–380.
4.
Torres‐Durán, María, Alice Turner, Hanan Tanash, et al.. (2024). Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry. Archivos de Bronconeumología. 61(1). 22–30. 4 indexed citations
5.
Tanash, Hanan, et al.. (2024). COVID-19 in Individuals with Severe Alpha 1-Antitrypsin Deficiency. International Journal of COPD. Volume 19. 2661–2669.
6.
Stockley, R A, Ingrid Louise Titlestad, Hanan Tanash, et al.. (2023). Alvelestat, an Oral Neutrophil Elastase Inhibitor in Alpha-1 Antitrypsin Deficiency (AATD): Results of a Phase II Trial. A4493–A4493.
7.
Piitulainen, Eeva, et al.. (2022). The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening. SHILAP Revista de lepidopterología. 1 indexed citations
8.
Parr, David, Joanna Chorostowska‐Wynimko, Angelo Guido Corsico, et al.. (2022). Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration. Archivos de Bronconeumología. 58(12). 840–842. 7 indexed citations
9.
Ekström, Magnus, et al.. (2021). Severe alpha‐1‐antitrypsin deficiency increases the risk of venous thromboembolism. Journal of Thrombosis and Haemostasis. 19(6). 1519–1525. 10 indexed citations
10.
Davies, Joanna M., Zainab Ahmadi, David C. Currow, et al.. (2020). Indications and patterns of use of benzodiazepines and opioids in severe interstitial lung disease: a population-based longitudinal study. ERJ Open Research. 7(1). 716–2020. 5 indexed citations
11.
Tanash, Hanan, et al.. (2020). <p>Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population</p>. International Journal of COPD. Volume 15. 1245–1252. 6 indexed citations
12.
Piitulainen, Eeva, et al.. (2019). Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Díaz, Sandra, et al.. (2018). Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency. International Journal of COPD. Volume 13. 3689–3698. 13 indexed citations
14.
Ekström, Magnus & Hanan Tanash. (2017). Lung transplantation and survival outcomes in patients with oxygen-dependent COPD with regard to their alpha-1 antitrypsin deficiency status. International Journal of COPD. Volume 12. 3281–3287. 6 indexed citations
15.
Tanash, Hanan, Magnus Ekström, Eva Rönmark, Anne Lindberg, & Eeva Piitulainen. (2017). Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits. European Respiratory Journal. 50(3). 1700198–1700198. 38 indexed citations
16.
Ekström, Magnus, Gerdt C. Riise, & Hanan Tanash. (2017). Risk of cancer after lung transplantation for COPD. International Journal of COPD. Volume 12. 2841–2847. 9 indexed citations
17.
Tanash, Hanan, Magnus Ekström, Philippe Wagner, & Eeva Piitulainen. (2016). Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden. International Journal of COPD. Volume 11. 1663–1669. 27 indexed citations
18.
Tanash, Hanan, et al.. (2015). The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34. Annals of the American Thoracic Society. 12(6). 807–812. 19 indexed citations
19.
Tanash, Hanan, Gerdt C. Riise, Magnus Ekström, Lennart Hansson, & Eeva Piitulainen. (2014). Survival Benefit of Lung Transplantation for Chronic Obstructive Pulmonary Disease in Sweden. The Annals of Thoracic Surgery. 98(6). 1930–1935. 14 indexed citations
20.
Tanash, Hanan, et al.. (2008). Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ). Thorax. 63(12). 1091–1095. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Luisetti Breakdown of academic impact, for papers by Sung-Nam Lim Breakdown of academic impact, for papers by Robert Virtala Breakdown of academic impact, for papers by Lijuan Li Breakdown of academic impact, for papers by Ana Lívia Silva Galbiatti Breakdown of academic impact, for papers by José R. Borbolla‐Escoboza Breakdown of academic impact, for papers by Francesca Mariani Breakdown of academic impact, for papers by Habib M. Ghaddar Breakdown of academic impact, for papers by Yongqiang Zhao
Rankless by CCL
2026